PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
130 hedge funds and large institutions have $348M invested in PhenomeX Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 45 reducing their positions, and 26 closing their positions.
1% more call options, than puts
Call options by funds: $879K | Put options by funds: $869K
4% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 26
2% less funds holding
Funds holding: 132 → 130 (-2)
16% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 45
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
61% less capital invested
Capital invested by funds: $899M → $348M (-$550M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$15.7M |
| 2 |
Morgan Stanley
New York
|
+$13.1M |
| 3 |
GCM
Glenview Capital Management
New York
|
+$9.87M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$9.61M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$23M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.2M |
| 3 |
Millennium Management
New York
|
-$15.6M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$14.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$9.65M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
151
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$1K | -28 | Closed |
|
|
PFS
152
Prospera Financial Services
Dallas,
Texas
| – | +$505 | +61 | New |
|
153
Rockefeller Capital Management
New York
| – | +$1.22K | +148 | +247% |
|
CELL Hedge Fund Activity: Q1 2022 in Review
130 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q1 2022, worth a combined $348M — down 61% from $899M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of CELL and 25 opened new positions — a net loss of 1 holder — while 45 trimmed existing stakes and 38 added.
The largest buyer was Federated Hermes, adding an estimated $15.7M. The largest seller was Invesco, cutting an estimated $23M.
- 130 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q1 2022, down from 132 in Q4 2021.
- Funds reported $348M of PhenomeX Inc. Common Stock stock for Q1 2022, down 61% quarter-over-quarter.
- 25 funds opened new PhenomeX Inc. Common Stock positions in Q1 2022 and 26 closed out, a net change of -1 holder.
- The largest PhenomeX Inc. Common Stock buyer in Q1 2022 was Federated Hermes, an estimated $15.7M added.
- The largest PhenomeX Inc. Common Stock seller in Q1 2022 was Invesco, an estimated $23M sold.
Based on aggregated 13F filings for Q1 2022.